{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T17:05:37Z","timestamp":1779555937775,"version":"3.53.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.prp.2026.156519","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:24:12Z","timestamp":1778552652000},"page":"156519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lactylation-induced TRIM47 exacerbates cell viability, cell cycle progression, and glycolysis in thyroid cancer by inducing ubiquitin-mediated degradation of FBP1"],"prefix":"10.1016","volume":"284","author":[{"given":"Faren","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caibing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156519_bib1","first-page":"940","article-title":"Comparison of disease burden factors of thyroid cancer Between China and the World From 1990 to 2019","volume":"45","author":"Su","year":"2023","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.prp.2026.156519_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115173","article-title":"Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies","volume":"26","author":"Forma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156519_bib3","doi-asserted-by":"crossref","first-page":"93869","DOI":"10.5493\/wjem.v14.i3.93869","article-title":"Interaction between tumor stage and age on survival outcomes of patients with anaplastic thyroid cancer","volume":"14","author":"Bangolo","year":"2024","journal-title":"World J. Exp. Med."},{"key":"10.1016\/j.prp.2026.156519_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5306\/wjco.v13.i1.9","article-title":"New approaches for patients with advanced radioiodine-refractory thyroid cancer","volume":"13","author":"Pitoia","year":"2022","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156519_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.7150\/thno.105353","article-title":"Lactylation in health and disease: physiological or pathological?","volume":"15","author":"Zhao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156519_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156519_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13062-024-00555-1","article-title":"TRIM47 drives gastric cancer cell proliferation and invasion by regulating CYLD protein stability","volume":"19","author":"Wang","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.prp.2026.156519_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100122","article-title":"TRIM47 promotes ovarian cancer cell proliferation, migration, and invasion by activating STAT3 signaling","volume":"77","author":"Wang","year":"2022","journal-title":"Clinics"},{"key":"10.1016\/j.prp.2026.156519_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102164","article-title":"TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1","volume":"51","author":"Xu","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.prp.2026.156519_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s10020-025-01298-z","article-title":"Tripartite motif 47 promotes the development of thyroid carcinoma through ADAR ubiquitination","volume":"31","author":"Liu","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.prp.2026.156519_bib11","doi-asserted-by":"crossref","first-page":"29167","DOI":"10.1038\/s41598-024-81017-6","article-title":"FBP1 over-expression suppresses HIF-1alpha in papillary thyroid cancer","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156519_bib12","article-title":"Overexpression of FBP1 enhances dendritic cell activation and maturation by inhibiting glycolysis and promoting the secretion of IL33 in lung adenocarcinoma","volume":"1871","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.prp.2026.156519_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00018-024-05138-x","article-title":"FBP1 inhibits NSCLC stemness by promoting ubiquitination of Notch1 intracellular domain and accelerating degradation","volume":"81","author":"He","year":"2024","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.prp.2026.156519_bib14","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.21037\/tau-23-605","article-title":"TRIM47 promotes the Warburg effect and reduces ferroptosis in prostate cancer by FBP1 and FOXO1","volume":"13","author":"Zhao","year":"2024","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.prp.2026.156519_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70753","article-title":"TRIM47 facilitates osteosarcoma progression via destabilising FBP1 and thus activation of Wnt\/beta-catenin pathway","volume":"29","author":"Wang","year":"2025","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.prp.2026.156519_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08580-w","article-title":"Histone lactylation-driven feedback loop modulates pyrimidine metabolism to promote oral carcinogenesis","volume":"17","author":"Wang","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2026.156519_bib17","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.7150\/ijbs.120277","article-title":"Tumor-derived lactate drives malignant progression of refractory papillary thyroid carcinoma via the H3K18la-STAT1-LDHA Axis","volume":"21","author":"Zhou","year":"2025","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156519_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202416996","article-title":"TRIM47 regulates energy metabolism via glycolytic reprogramming to drive hepatocellular carcinoma progression and represents an efficient therapeutic target","volume":"13","author":"Sun","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.prp.2026.156519_bib19","article-title":"TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination","volume":"28","author":"Yu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.prp.2026.156519_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12935-021-01831-0","article-title":"TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.prp.2026.156519_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.21037\/tcr-22-2200","article-title":"Down-regulation of FBP1 in lung adenocarcinoma cells promotes proliferation and invasion through SLUG mediated epithelial mesenchymal transformation","volume":"12","author":"Wang","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.prp.2026.156519_bib22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/1759-7714.14750","article-title":"FBP1 induced by beta-elemene enhances the sensitivity of gefitinib in lung cancer","volume":"14","author":"Li","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.prp.2026.156519_bib23","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18926","article-title":"Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma","volume":"13","author":"Lu","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.prp.2026.156519_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41392-024-01918-w","article-title":"Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2026.156519_bib25","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.7150\/thno.104858","article-title":"Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156519_bib26","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.7150\/thno.105947","article-title":"Histone lactylation-driven B7-H3 expression promotes tumor immune evasion","volume":"15","author":"Ma","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156519_bib27","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1007\/s40121-025-01232-0","article-title":"The Roles of Histone H3K18 lactylation, acetylation, and lactylation\/acetylation ratio as potential biomarkers in the diagnosis and severity assessment of sepsis and septic shock","volume":"14","author":"Di","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.prp.2026.156519_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3119375","article-title":"Tumor microenvironment: lactic acid promotes tumor development","volume":"2022","author":"Gao","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.prp.2026.156519_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382600172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:47:02Z","timestamp":1779554822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382600172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S034403382600172X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156519","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lactylation-induced TRIM47 exacerbates cell viability, cell cycle progression, and glycolysis in thyroid cancer by inducing ubiquitin-mediated degradation of FBP1","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156519"}}